Search results
TD Cowen Raises BioNTech (NASDAQ:BNTX) Price Target to $98.00
ETF DAILY NEWS· 3 days agoThe brokerage currently has a hold rating on the stock. BMO Capital Markets cut their target price on BioNTech from $123.00 to $122.00 ...
What's Going With BioNTech Stock On Monday?
Benzinga· 7 days agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders...
Simply Wall St. via Yahoo Finance· 2 days agoWith a total shareholder return of -52% over three years, BioNTech SE shareholders would by and...
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 7 days agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
BioNTech shares hold rating, price target raised By Investing.com
Investing.com· 6 days agoTuesday, BioNTech SE (NASDAQ:BNTX) shares maintained their Hold rating, but with an updated price...
BMO Capital cuts BioNTech stock target, keeps Outperform By Investing.com
Investing.com· 6 days agoOn Tuesday, BMO Capital Markets adjusted its price target for shares of BioNTech (NASDAQ:BNTX), a...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 4 days agoThe reason Novavax's stock chart looks so wild has to do with its promise and missed opportunity...
Cracking The Code: Understanding Analyst Reviews For BioNTech - BioNTech (NASDAQ:BNTX)
Benzinga· 6 days agoDebt Management: BioNTech's debt-to-equity ratio is below the industry average at 0.01 , reflecting a lower dependency on debt financing and a more conservative financial.
Vertex Beats Quarterly Forecasts, But Its Pipeline Remains Key
Investor's Business Daily· 7 days agoAlthough Vertex Pharmaceuticals (VRTX) is the de facto leader of the market for cystic fibrosis...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 days agoThe company is a leader in the neuroscience space. Neurocrine recently asked the Food and Drug...